<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1646-706X</journal-id>
<journal-title><![CDATA[Angiologia e Cirurgia Vascular]]></journal-title>
<abbrev-journal-title><![CDATA[Angiol Cir Vasc]]></abbrev-journal-title>
<issn>1646-706X</issn>
<publisher>
<publisher-name><![CDATA[Sociedade Portuguesa de Angiologia e Cirurgia Vascular]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1646-706X2021000400344</article-id>
<article-id pub-id-type="doi">10.48750/acv.304</article-id>
<title-group>
<article-title xml:lang="pt"><![CDATA[Tratamento endovascular no síndrome pós-trombótico secundário a fibroma uterino]]></article-title>
<article-title xml:lang="en"><![CDATA[Endovascular treatment for postthrombotic syndrome due to uterine fibroids]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Sousa]]></surname>
<given-names><![CDATA[Pedro Pinto]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Centro Hospitalar Vila Nova de Gaia / Espinho Serviço de Angiologia e Cirurgia Vascular ]]></institution>
<addr-line><![CDATA[Vila Nova de Gaia ]]></addr-line>
<country>Portugal</country>
</aff>
<pub-date pub-type="pub">
<day>30</day>
<month>12</month>
<year>2021</year>
</pub-date>
<pub-date pub-type="epub">
<day>30</day>
<month>12</month>
<year>2021</year>
</pub-date>
<volume>17</volume>
<numero>4</numero>
<fpage>344</fpage>
<lpage>348</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.pt/scielo.php?script=sci_arttext&amp;pid=S1646-706X2021000400344&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.pt/scielo.php?script=sci_abstract&amp;pid=S1646-706X2021000400344&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.pt/scielo.php?script=sci_pdf&amp;pid=S1646-706X2021000400344&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="pt"><p><![CDATA[Resumo Os fibromas uterinos são o tumor sólido pélvico mais frequente nas mulheres, geralmente condicionando hipomenorreia. Não costumam estar associados a trombose venosa profunda, mas, quando atingem dimensões consideráveis podem condicionar fenómenos compressivos a nível da veia cava inferior e veias pélvicas e consequentes fenómenos trombóticos. Posteriormente, as lesões obstrutivas pós-trombóticas das veias ilíacas poderão levar ao desenvolvimento de clínica e sintomas compatíveis com doença venosa crónica. Se por um lado não existe indicação para intervenção profilática, quando essas lesões desenvolvem sintomas apesar do melhor tratamento médico (Classificação CEAP C3-6), está recomendada a sua correção via endovascular com recurso a stenting. Estas intervenções são procedimentos seguros e eficazes associadas a uma reduzida taxa de complicações,na ordem dos 0.4%. Os autores descrevem um caso clínico de uma utente do sexo feminino, de 47 anos, que desenvolveu síndrome pós-trombótico no contexto de um fibroma uterino de grandes dimensões, corrigido com recurso a tratamento endovascular.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract Uterine fibroids are the most common solid pelvic tumors in women, frequently causing hypomenorrhea. They normally do not carry an increased risk for deep venous thrombosis (DVT) unless they reach a considerable size conditioning inferior vena cava and pelvic veins compression. Postthrombotic iliac vein obstructive lesions resulting from a prior episode of DVT may lead to clinical signs and symptoms of chronic vein disease. There is no role for prophylactic treatment of silent lesions. However, if patients develop advanced symptoms (CEAP C3-C6 classification) despite best medical treatment, patients are candidates for endovascular correction with stenting. Endovenous correction of ilio-caval pathology is associated with high technical success rate and reduced complications, around 0.4%. The authors describe a clinical case of a 47 years-old female patient that developed post-thrombotic syndrome due to a DVT, caused by compression from a large uterine fibroid, treated with endovascular surgery.]]></p></abstract>
<kwd-group>
<kwd lng="pt"><![CDATA[Fibroma uterino]]></kwd>
<kwd lng="pt"><![CDATA[Trombose venosa profunda]]></kwd>
<kwd lng="pt"><![CDATA[Sindrome pós trombótico]]></kwd>
<kwd lng="pt"><![CDATA[Endovascular]]></kwd>
<kwd lng="pt"><![CDATA[Stenting ilio-cava]]></kwd>
<kwd lng="en"><![CDATA[Uterine fibroids]]></kwd>
<kwd lng="en"><![CDATA[Deep venous thrombosis]]></kwd>
<kwd lng="en"><![CDATA[Post-thrombotic syndrome]]></kwd>
<kwd lng="en"><![CDATA[Endovascular]]></kwd>
<kwd lng="en"><![CDATA[Ilio-caval stenting]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Donnez]]></surname>
<given-names><![CDATA[Jacques]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Uterine fibroid management: from the present to the future]]></article-title>
<source><![CDATA[Hum Reprod Update]]></source>
<year>2016</year>
<volume>22</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>665-86</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Faria]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Godinho]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Rodrigues]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Miomas uterinos: revisao da literatura]]></article-title>
<source><![CDATA[Acta Obstet Ginecol Port]]></source>
<year>2008</year>
<volume>2</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>131-42</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wallach E]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Vlahos N]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Uterine myomas an overview of development, clinical features and management]]></article-title>
<source><![CDATA[Obstet Gynecol]]></source>
<year>2004</year>
<volume>104</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>393-406</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chong]]></surname>
<given-names><![CDATA[Y.S.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Deep vein thrombosis in patients with large uterine myomata]]></article-title>
<source><![CDATA[Obstet. Gynecol.]]></source>
<year>1998</year>
<volume>9</volume>
<page-range>707</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Dekel]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Thrombosis of the pelvic veins associated with a large myomatous uterus]]></article-title>
<source><![CDATA[Obstet. Gynecolo.]]></source>
<year>1998</year>
<volume>92</volume>
<page-range>646-7</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Tanaka]]></surname>
<given-names><![CDATA[H.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Venous thromboembolic diseases associated with uterine myomas diagnosed before hysterectomy. A report of two cases]]></article-title>
<source><![CDATA[J. Obstet. Gynaecol.]]></source>
<year>2002</year>
<volume>28</volume>
<page-range>300-3</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Silva]]></surname>
<given-names><![CDATA[Pedro Tiago]]></given-names>
</name>
</person-group>
<source><![CDATA[Consenso Nacional sobre Miomas uterinos - tratamento médico]]></source>
<year>2017</year>
</nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Overhagen]]></surname>
<given-names><![CDATA[Hans van]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Uterina artery embolization for symptomatic leiomyomata]]></article-title>
<source><![CDATA[Cardiovascuar and Interventional radiology]]></source>
<year>2015</year>
<volume>38</volume>
<page-range>536-42</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pascarella]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Schonbein]]></surname>
<given-names><![CDATA[GW]]></given-names>
</name>
<name>
<surname><![CDATA[Bergan]]></surname>
<given-names><![CDATA[JJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Microcirculation and venous ulcers a review]]></article-title>
<source><![CDATA[Ann Vasc Surg]]></source>
<year>2005</year>
<volume>19</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>921-7</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hartung]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Loundou]]></surname>
<given-names><![CDATA[AD]]></given-names>
</name>
<name>
<surname><![CDATA[Barthelemy]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Arnoux]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Boufi]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Alimi]]></surname>
<given-names><![CDATA[YS]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Endovascular management of chronic disabling ilio- caval obstructive lesions long-term results]]></article-title>
<source><![CDATA[Eur J Vasc Endo- vasc Surg]]></source>
<year>2009</year>
<volume>38</volume>
<page-range>118e24</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Milinis]]></surname>
<given-names><![CDATA[Kristijonas]]></given-names>
</name>
</person-group>
<source><![CDATA[Antithrombotic Therapy following venous stenting: International Delphi Consensus]]></source>
<year>2018</year>
</nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Zhang]]></surname>
<given-names><![CDATA[Xicheng]]></given-names>
</name>
</person-group>
<source><![CDATA[Long-term follow up of the stenting across the iliocaval confluence in patients with iliac venous lesions]]></source>
<year>2019</year>
</nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Guillen]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<source><![CDATA[Endovascular stenting for chronic femoro-iliac venous obstructive disease: clinical efficacy and short-term outcomes]]></source>
<year>2020</year>
</nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Alhalbouni]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Hingorani]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Shiferson]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Gopal]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Jung]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Novak]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Iliac-femoral venous stenting for lower ex- tremity venous stasis symptoms]]></article-title>
<source><![CDATA[Ann Vasc Surg]]></source>
<year>2012</year>
<volume>26</volume>
<page-range>185e9</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Neglen]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Berry]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Raju]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Endovascular surgery in the treatment of chronic primary and post-thrombotic iliac vein obstruction]]></article-title>
<source><![CDATA[Eur J Vasc Endovasc Surg]]></source>
<year>2000</year>
<volume>20</volume>
<page-range>560e71</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sidawy]]></surname>
<given-names><![CDATA[Anton N.]]></given-names>
</name>
</person-group>
<source><![CDATA[Rutherford's Vascular surgery and endovascular therapy]]></source>
<year>2018</year>
<edition>9</edition>
</nlm-citation>
</ref>
</ref-list>
</back>
</article>
